Based on these immune responses to p210 vaccine and the reported participation of CD8+ T cells in hypertension and kidney dysfunction, we hypothesized that p210 vaccine would modulate the hypertensive response in AngII-infused apoE (-/-) mice. The gene discussed is EVPL; the disease is hypertensive disorder.